article · Kidney International Reports
Lupus nephritis (LN) is a common complication of systemic lupus erythematosus (SLE) diagnosed via histopathology of renal biopsy. Investigating surrogate markers to predict renal involvement in LN is a safe non-invasive method to be studied. One of those markers is Interleukin 35 (IL-35) which has an immunosuppressive and anti-inflammatory role in many autoimmune diseases. However, its role in LN still needs to be elucidated. This study aimed to evaluate serum levels of IL-35 in SLE patients with and without LN as a biomarker of renal involvement.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.ekir.2024.02.349
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
